Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.